Answers are grounded in this paper and cite their sources.
Diabetic nephropathy (DN) is a major complication of diabetes characterized by metabolic dysregulation, inflammation, and progressive renal injury. This study integrated transcriptomic analysis, molecular network reconstruction, regulatory network analysis, and structure-based virtual screening to prioritize candidate disease-associated targets and natural compounds. RNA-sequencing data from human kidney biopsies were analyzed to identify differentially expressed genes, with downstream target prioritization focused on upregulated genes. Protein–protein interaction and regulatory network analyses highlighted candidate networks associated with immune activation, inflammatory signaling, and extracellular matrix organization. A panel of 29 protein targets was selected for molecular docking, and 640 candidate natural compounds retrieved from the LOTUS database were screened using AutoDock Vina. Redocking validation and residue-level Jaccard analysis provided complementary assessments of pose recovery and contact-residue overlap in three selected protein–ligand complexes. Network analysis prioritized compounds including Withacoagin, Withanolide A, and other withanolide-related candidates based on their predicted docking scores and retained ligand–target associations. These results provide computational hypotheses for investigating candidate multi-target ligands in DN. Experimental studies are required to establish binding, functional effects, and therapeutic relevance.
No takes yet. Share an insight, caveat, or question.
Kori et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: